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Introduction
Allometric scaling is widely used in predicting human clearance (CL) based on animal data. Since prediction errors are commonly observed in the practical application of this approach, various modifications to allometric scaling have been proposed. These modifications include: in vitro metabolic data (Lave, et al., 1997) ; correcting by either maximum life-span potential (MLP) or brain weight (BrW) (Mahmood and Balian, DMD #4143 allometry, this method is still not satisfactory in predicting large vertical allometry. More recent studies (Nagilla and Ward, 2004) found that the corrections using MLP or BrW or the 'rule of exponents' in allometric scaling did not result in significant improvements in predictions of human CL. Furthermore, Ward et al. proposed that the monkey liver blood flow approach was superior to the 'rule of exponents'. This controversy is currently not resolved (Mahmood, 2005; Nagilla and Ward, 2005) .
The coefficients (a) of the power function have been considered important in determining the magnitude of CL, because the exponents (b) have been shown to be relatively constant with a typical value close to 0.75 (Boxenbaum, 1982) . Based upon analysis of more than 60 drugs we have observed that the water-octanol partition coefficient (logP) and the ratio of unbound fraction (f u ) in plasma between rats and humans (Rf u ) may provide simple rules for anticipating the occurrence of large vertical allometry. Based upon these findings, therefore, we attempted to develop a new model for predicting human CL.
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Methods
A literature search was performed to obtain animal data for allometric scaling of systemic CL (CL used in this article refers to systemic CL) and f u ratio in rats and humans. Only data sets including at least three animal species were used for scaling.
Coefficients and exponents were obtained by fitting: body weight and CL; CL×MLP; or CL×BrW on a log-log scale according to the allometric equation (Boxenbaum, 1982) . The rule of exponents was applied as described by Mahmood: 1) if the exponent from simple allometry is between 0.55 and 0.70, simple allometry is applied; 2) if the exponent is between 0.70 and 1.0, CL×MLP approach is applied; 3) if the exponent is greater than 1.0, CL×BrW approach is applied; 4) if the exponent is less than 0.50, simple allometry is applied since none of the approaches could improve the prediction (Mahmood and Balian, 1996a 
Results
The interest and rationale for developing a new allometric model equation was based on our previous findings that Rf u , combined with ClogP could be used to formulate rules to predict qualitatively the occurrence of large vertical allometry in predicting human CL (Tang and Mayersohn, Journal of Pharmaceutical Science, in press). The current study was undertaken to create and test a model in which parameters such as Rf u , ClogP, as well as coefficient a and exponent b from simple allometry, could potentially be useful to quantitatively predict human CL. ClogP was removed from the model since it did not add any statistical improvement. Coefficient a, exponent b and Rf u were found to be statistically significant with P-values of < 0. 
Discussion
The use of f u ratio between rats and humans, rather than between all animals and humans, was based on our observation that the f u in rats is representative of the average f u in animals (Figure 1 ). In contrast, many significant differences between f u in rats and f u in humans were observed (Figure 1) . One question could be raised concerning why scaling by the unbound CL approach did not provide stable and good predictability, because it appears that correcting CL by f u in each animal species would be more favorable than just considering only rats and humans. One possible explanation could be attributed to the serious error underlying data fitting to the power function (Smith, 1984) and the considerable measurement error of f u , especially for highly plasma bound compounds.
When three or more animal species are included for scaling unbound CL, the same number of f u variables with errors are also introduced into the data fitting, and may generate greater error in predicting human values than what is generated from the error noted in only one species, the rat, in the new proposed model. Here is an example to visualize this concept. Suppose three species, mouse (0.03 kg), rat (0.25 kg) and dog (15 kg), are used for allometric scaling of unbound CL. The final predicted CL in humans by allometry can be expressed as:
where A is a function of CL observed in each animal species and the body weight of animals (derivation in Appendix). The new model can be expressed as:
This article has not been copyedited and formatted. The final version may differ from this version. in vitro metabolic differences across species, which may account for deviations in predictions. Therefore, the empirical model that has been proposed should be expected, in practice, to result in errors in prediction, such as when a significant metabolic/elimination difference is seen across the species examined. Nevertheless, the new model was shown to be simple, reasonable, and more predictive than the currently available approaches. In particular, the new model significantly improves for the first time the prediction of the occurrence of large vertical allometry noted in humans.
In summary, a novel and simple model, incorporating a and f u ratio between rats and humans, has been proposed and shown to provide a better predictability than the currently available allometric techniques in estimating values of CL in humans. Most important, it significantly improves the prediction of large vertical allometry.
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Appendix: Derivation of Equation 5
Part I: Derivation of the function relating predicted PK parameters in humans (P predicted ) to animal body weights (W) and observed animal PK parameters (P i ).
The log-log transformation of,
Then, Equation (1) can be simplified to,
Suppose n different animal species are used for allometric scaling. Therefore, there are n sets of (X, Y) data to fit using linear regression. Based on the method of least squares for linear regression, α and β can be calculated as, 
